We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Norwegian Cruise Line
NCLH
$9.2B
| $1.75M | 0.08% |
+32,675
| New | +$1.82M |
|
277
Incyte
INCY
$23.7B
| $1.73M | 0.08% |
+20,334
| New | +$1.63M |
|
278
The GEO Group
GEO
$4.13B
| $1.72M | 0.08% |
82,032
-1,517
| -2% | -$32K |
|
279
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.69M | 0.08% |
19,706
-17,240
| -47% | -$1.47M |
|
|
SRC
280
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $1.68M | 0.08% |
39,283
+12,018
| +44% | +$507K |
|
|
COUP
281
DELISTED
Coupa Software Incorporated
COUP
| $1.67M | 0.07% |
13,217
+9,760
| +282% | +$1.05M |
|
|
NEWR
282
DELISTED
New Relic, Inc.
NEWR
| $1.65M | 0.07% |
19,052
-25,015
| -57% | -$2.47M |
|
283
Tandem Diabetes Care
TNDM
$1.18B
| $1.64M | 0.07% |
25,445
+5,947
| +31% | +$384K |
|
284
National Fuel Gas
NFG
$7.67B
| $1.62M | 0.07% |
+30,769
| New | +$1.75M |
|
285
KB Home
KBH
$3.53B
| $1.62M | 0.07% |
+63,025
| New | +$1.62M |
|
286
Cousins Properties
CUZ
$5.28B
| $1.62M | 0.07% |
44,687
+22,609
| +102% | +$849K |
|
287
ArcelorMittal
MT
$50.9B
| $1.6M | 0.07% |
88,757
+34,424
| +63% | +$649K |
|
288
Ally Financial
ALLY
$13.3B
| $1.59M | 0.07% |
+51,425
| New | +$1.52M |
|
289
Cheniere Energy
LNG
$53.6B
| $1.59M | 0.07% |
23,262
+14,902
| +178% | +$986K |
|
290
UGI
UGI
$7.91B
| $1.59M | 0.07% |
+29,724
| New | +$1.58M |
|
291
Moody's
MCO
$84.2B
| $1.58M | 0.07% |
+8,081
| New | +$1.53M |
|
292
Roku
ROKU
$21.2B
| $1.57M | 0.07% |
17,341
-18,253
| -51% | -$1.47M |
|
293
Chipotle Mexican Grill
CMG
$42.6B
| $1.55M | 0.07% |
+105,850
| New | +$1.49M |
|
294
Edwards Lifesciences
EW
$47.8B
| $1.54M | 0.07% |
+25,038
| New | +$1.51M |
|
295
HealthEquity
HQY
$8.28B
| $1.54M | 0.07% |
+23,566
| New | +$1.64M |
|
296
Henry Schein
HSIC
$9.64B
| $1.53M | 0.07% |
+21,962
| New | +$1.45M |
|
297
NetEase
NTES
$79.2B
| $1.53M | 0.07% |
29,940
+15,370
| +105% | +$816K |
|
298
LyondellBasell Industries
LYB
$18.9B
| $1.52M | 0.07% |
+17,623
| New | +$1.5M |
|
299
Sysco
SYY
$40.2B
| $1.52M | 0.07% |
21,456
-242,417
| -92% | -$17.3M |
|
300
iShares US Real Estate ETF
IYR
$4.73B
| $1.51M | 0.07% |
+17,316
| New | +$1.52M |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.